146 related articles for article (PubMed ID: 29116563)
21. Searing abdomen: Infrequent presentation of peritoneal lymphomatosis in Diffuse Large B-Cell Lymphoma on 18F-FDG PET-CT scan.
Asghar N; Ahmad W; Hassan A
J Pak Med Assoc; 2022 Aug; 72(8):1670-1671. PubMed ID: 36280945
[No Abstract] [Full Text] [Related]
22. Intravascular Large B-Cell Lymphoma Identified by PET/CT.
Liu W; Liu M; Guan M; Huang J; Xie P
Clin Nucl Med; 2023 Jun; 48(6):528-529. PubMed ID: 37019128
[TBL] [Abstract][Full Text] [Related]
23. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
24. PET/CT imaging of renal intravascular large B-cell lymphoma.
Narita K; Suzuki T; Matsue K
Clin Exp Nephrol; 2022 Nov; 26(11):1144-1145. PubMed ID: 35908129
[No Abstract] [Full Text] [Related]
25. Disseminated Lymphoma Evolving into Neurolymphomatosis during Mid-cycle of Chemotherapy Detected by (18)F-FDG PET/CT.
Tong AK; Neo SH; Kok TY
Ann Acad Med Singap; 2015 Nov; 44(11):545-7. PubMed ID: 27089963
[No Abstract] [Full Text] [Related]
26. F-18 FDG PET and Ga-67 scintigraphy in a case of fever of unknown origin with underlying cutaneous diffuse large B-Cell lymphoma.
Hsieh HJ; Lin SH; Chu YK; Chang CP; Liu RS
Clin Nucl Med; 2004 Dec; 29(12):859-60. PubMed ID: 15545909
[No Abstract] [Full Text] [Related]
27. FDG PET/CT Findings in Primary Diffuse Large B-cell Lymphoma, Leg Type.
Ni C; Lewis M; Berenji G
Clin Nucl Med; 2016 Jan; 41(1):65-8. PubMed ID: 26447379
[TBL] [Abstract][Full Text] [Related]
28. FDG-PET guided diagnosis of vaginal intravascular diffuse large B-cell lymphoma.
Hemmaway CJ; Danga A; Igbokwe U; Radunovic A
Br J Haematol; 2012 Sep; 158(6):678. PubMed ID: 22823157
[No Abstract] [Full Text] [Related]
29. Neurolymphomatosis as a late relapse of non-Hodgkin's lymphoma detected by 18F-FDG PET/CT: a case report.
Kajáry K; Molnár Z; Mikó I; Barsi P; Lengyel Z; Szakáll S
Rev Esp Med Nucl Imagen Mol; 2014; 33(1):39-42. PubMed ID: 23683830
[TBL] [Abstract][Full Text] [Related]
30. The value of 18F-FDG PET/CT in evaluating the efficacy of chemotherapy for diffuse large B-cell lymphoma with cardiac involvement.
Yang Y; Chen P; Liu L; Lin J; Huang S
J Nucl Cardiol; 2022 Dec; 29(6):3548-3553. PubMed ID: 33660215
[No Abstract] [Full Text] [Related]
31. A new diagnostic marker for differentiating multicentric gliomas from multiple intracranial diffuse large B-cell lymphomas on 18F-FDG PET images.
Wang K; Zhao X; Chen Q; Fan D; Qiao Z; Lin S; Jiang T; Dai J; Ai L
Medicine (Baltimore); 2017 Aug; 96(32):e7756. PubMed ID: 28796066
[TBL] [Abstract][Full Text] [Related]
32. [The outcome of whole-body FDG-PET examination predicts the future of patients with diffuse large-cell lymphoma--editorial].
Klabusay M
Vnitr Lek; 2007 Sep; 53(9):918. PubMed ID: 18019653
[No Abstract] [Full Text] [Related]
33. An update on the role of interim restaging FDG-PET in patients with diffuse large B-cell lymphoma and Hodgkin lymphoma.
Moskowitz CH; Zelenetz A; Schoder H
J Natl Compr Canc Netw; 2010 Mar; 8(3):347-52. PubMed ID: 20202464
[TBL] [Abstract][Full Text] [Related]
34. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading.
Wöhrer S; Jaeger U; Kletter K; Becherer A; Hauswirth A; Turetschek K; Raderer M; Hoffmann M
Ann Oncol; 2006 May; 17(5):780-4. PubMed ID: 16497824
[TBL] [Abstract][Full Text] [Related]
35. Evidence-based reflection on the value of FDG-PET for interim and end-of-treatment response assessment in diffuse large B-cell lymphoma.
Adams HJ; Kwee TC
Ann Hematol; 2015 Sep; 94(9):1611-3. PubMed ID: 26063192
[No Abstract] [Full Text] [Related]
36. Tumour necrosis as assessed with
Kahle XU; Hovingh M; Noordzij W; Seitz A; Diepstra A; Visser L; van den Berg A; van Meerten T; Huls G; Boellaard R; Kwee TC; Nijland M
Eur Radiol; 2019 Nov; 29(11):6018-6028. PubMed ID: 31028445
[TBL] [Abstract][Full Text] [Related]
37. Distinct FDG PET/CT avidity among newly diagnosed intravascular large B-cell lymphoma patients: a descriptive observational study.
Zhao D; Zhang Y; Zhu W; Huo L; Zhou D; Wang W; Wei C; Zhang W
Ann Hematol; 2024 Feb; 103(2):545-552. PubMed ID: 37932469
[TBL] [Abstract][Full Text] [Related]
38. Distal appendicular skeletal involvement of diffuse large B-cell lymphoma on technetium-99m methylenediphosphonate bone scintigraphy and
Park I; Kang S
J Med Case Rep; 2017 Apr; 11(1):89. PubMed ID: 28372572
[TBL] [Abstract][Full Text] [Related]
39. [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.
Martelli M; Ceriani L; Zucca E; Zinzani PL; Ferreri AJ; Vitolo U; Stelitano C; Brusamolino E; Cabras MG; Rigacci L; Balzarotti M; Salvi F; Montoto S; Lopez-Guillermo A; Finolezzi E; Pileri SA; Davies A; Cavalli F; Giovanella L; Johnson PW
J Clin Oncol; 2014 Jun; 32(17):1769-75. PubMed ID: 24799481
[TBL] [Abstract][Full Text] [Related]
40. Can the interim fluorodeoxyglucose-positron emission tomography standardized uptake value be used to determine the need for residual mass biopsy after dose-dense immunochemotherapy for advanced diffuse large B-cell lymphoma?
Juweid ME; Smith B; Itti E; Meignan M
J Clin Oncol; 2010 Dec; 28(34):e719-20; author reply e721-2. PubMed ID: 20733137
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
